Cardiovascular Peptides Market - Global Industry Analysis,Trends And Forecast 2015 – 2023

Peptides are short chain of amino acids linked by peptide bonds. Usually they contain less than 50 amino acids. Natural cardiovascular peptides such as ANP and BNP are hormones of cardiac origin that play an important role in the regulation of cardiovascular homeostasis. Cardiovascular peptides are predominantly produced in heart, although many other tissues produced it but in amounts inadequate to induce any physiological effects. Advancement in biotechnology and pharmaceutical sciences has enable researchers to modify or mimic naturally occurring peptide for diverse therapeutic uses. One such example is Nesiritide, recombinant form of the 32 amino acid human B-type natriuretic peptide. Cardiovascular peptides are used in primarily to treat or avoid acute myocardial infarction, Coronary Ischemia, hypertension, Cardio metabolic Disease, heart failure, peripheral vascular diseases, and hematologic diseases. Browse Report With Full TOC At : http://www.transparencymarketresearch.com/cardiovascular-peptides-market.html

Cardiovascular Peptides Market - Global Industry Analysis,Trends And Forecast 2015 – 2023

Document download has been disabled by author

Please visit desktop version of this document